GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » Notes Receivable

U-Neuron Biomedical (ROCO:6973) Notes Receivable : NT$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is U-Neuron Biomedical Notes Receivable?

U-Neuron Biomedical's Notes Receivable for the quarter that ended in Dec. 2023 was NT$0.00 Mil.

U-Neuron Biomedical Notes Receivable Historical Data

The historical data trend for U-Neuron Biomedical's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U-Neuron Biomedical Notes Receivable Chart

U-Neuron Biomedical Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Notes Receivable
- - - -

U-Neuron Biomedical Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Notes Receivable - - - - -

U-Neuron Biomedical Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

U-Neuron Biomedical Notes Receivable Related Terms

Thank you for viewing the detailed overview of U-Neuron Biomedical's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

U-Neuron Biomedical (ROCO:6973) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » Notes Receivable
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
https://en.u-neuron.com
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.

U-Neuron Biomedical (ROCO:6973) Headlines

No Headlines